December 9, 2020 07:17 AM ESTUpdated 07:29 AM
Coronavirus

Covid-19 roundup: UAE claims Sinopharm vac­cine 86% ef­fec­tive, but de­tails are scant; In­dia re­port­ed­ly re­jects As­traZeneca's vac­cine, while UK con­ducts 'all en­com­pass­ing' re­view 

Amber Tong

Nicole DeFeudis

Editor

Over the past month we’ve learned, from Phase III tri­als, how well mR­NA and ade­n­ovirus-based vac­cines pro­tect peo­ple from Covid-19. And now, the first an­nounce­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

You bet your life: Af­ter I was di­ag­nosed with a rare can­cer, I dis­cov­ered how a small band of physi­cian-sci­en­tists ...

Biotech VC firm out­lines plans for $100M fund

No­vo says its CB1 drug helped shed weight, but ef­fi­ca­cy and safe­ty ques­tions re­main

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

A VC-backed ge­net­ic test­ing start­up to 'con­sid­er' mak­ing an of­fer to buy 23andMe

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times